Phase I/II trial of the tolerability and preliminary efficacy of a nanoparticulate formulation of doxorubicin in patients with liver cancer
Phase of Trial: Phase I/II
Latest Information Update: 06 Nov 2007
At a glance
- Drugs Doxorubicin (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Nov 2007 New trial record.